News

An extended-release injection formulation of granisetron (Sustol) has been approved by the FDA for use in combination with other antiemetic therapies for the prevention of CINV, according to the manufacturer of the treatment, Heron Therapeutics.

The health benefits of yoga are many, but in the oncology setting, studies of the approach have focused primarily on women with breast cancer. However, a small, first-of-its-kind study by researchers at the Perelman School of Medicine at the University of Pennsylvania is exploring how yoga may also improve treatment-related symptoms in men who are undergoing radiotherapy for their prostate cancer. And the results, thus far, are promising.

The Centers for Medicare & Medicaid (CMS) released the star ratings on its Hospital Compare website on July 27, 2016. The goal of the site is to enable healthcare consumers to locate information on hospital quality, conduct side-by-side comparisons of hospitals, and review the data on quality presented.

The field of breast cancer has evolved from the days of defaulting to chemotherapy for every patient, yet much work remains to individualize treatment. Though more promising novel regimens have become available, an expert urges clinicians to carefully weigh whether a particular new agent will provide a significant enough benefit to offset its associated toxicities, cost, and the time and commitment by the patient it requires.